维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="Fury MG"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	A phase-I trial of the epi- dermal growth factor receptor directed bispecifc antibody MDX- 447 without and with recombinant human granuloeyte-colony stimulating factor in patients with advanced solid tumors 显示文摘	Fury MG Lipton A Smith KM	2008	Cancer Immunol Immun2008，57，2：	1
2	A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy 显示文摘	Fury MG Antonescu CR Van Zee KJ	2005	Cancer J2005，11，3：	1
3	A phase 2 study of pemetrexedplus gemcitabine every 2 weeks for patients with recurrent or metastatic headand neck squamous cell cancer显示文摘	Fury MG Haque S Stambuk H et ai	2011	Cancer2011，117，4：	1
4	A phase Ⅰ trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors显示文摘	Fury MG Solit DB Su YB	2007	Cancer Chemother Pharmacol2007，59，：	1
5	Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review显示文摘	Laurie SA Ho AL Fury MG	2011	Lancet Oncol2011，12，8：	1
6	A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer显示文摘	Fury MG Sherman E Ho AL	2013	Cancer2013，119，10：	1
7	A Phase 1 study of everolimus+weekly cisplatin+intensity modulated radiation therapy in headand-neck cancer显示文摘	Fury MG Lee NY Sherman E	2013	Int J Radiat Oncol Biol Phys2013，87，3：	1
8	A phase I study of daily everolimus plus low-dose weekly cisplatin for patients with ad-vanced solid tumors 显示文摘	Fury MG Sherman E Haque S	2012	Cancer Chemother Pharmacol2012，69，：	1
9	A phase 2 study of hevacizum?ab with cisplatin plus intensity-modulated radiation therapy for stage m/NB head and neck squamous cell cancer显示文摘	Fury MG Lee NY Sherman E	2012	Cancer2012，118，20：	1
10	A Phase 1 study of everolimus plus weekly cisplatin plus intensity modulated radiation therapy in head and-neck cancer显示文摘	Fury MG Lee NY Sherman E		0，，3：	1
11	Induction chemotherapy in the management of head and neck cancer 显示文摘	Fury MG Shah JP	2010	J Surg 0ncol2010，101，4：	1
12	Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands:a systematic review显示文摘	Laurie SA Ho AL Fury MG		0，，08：	1
13	A phase 2 study ofbevacizumab with cisplatin plus intensity - modulated radi-ation therapy for stage III/IVB head and neck squamouscell cancer显示文摘	Fury MG Lee NY Sherman E	2012	Cancer2012，118，20：	1
14	A 14-year ret- rospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy显示文摘	Fury MG Antonescu CR Van Zee KJ el al	2005	Cancer J2005，11，3：	1
15	A phase I study of daily everolimus plus low-dose weekly cisplatin for patients with advanced solid tumors显示文摘	Fury MG Sherman E Haque S	2012	Cancer chemotherapy and pha rmacology2012，69，3：	1
16	A 14 year retrospec tive review of angiosarcoma:clinical characteristics, prognostic fac tors,and treatment outcomes with surgery and chemotherapy显示文摘	Fury MG Antonescu CR Van Zee KJ	2005	Cancer J2005，11，3：	1
17	A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors显示文摘	Fury MG Solit DB Su YB	2007	Cancer Chemother Pharmacol2007，59，4：	1
18	Phase II study of depsipeptide (DEP) in radioiodine (RAI)-refractory metastatic nonmedullary thy- roid carcinoma显示文摘	Sherman E Fury MG Tuttlc RM	2009	J Clin Oncol2009，27，15：	1
19	Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review显示文摘	Laurie SA Ho AL Fury MG	2011	Lancet Oncol2011，12，8：	1
20	Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands:a systematic review显示文摘	Laurie SA Ho AL Fury MG		0，，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示